在ETS之后的补偿性过症:时间演变和预测因素
Erhan Ozer1, Basak Gorusun2, Teoman Ekim3
1Bursa Uludag Universitesi, Nilüfer, Turkey.
The Thoracic and cardiovascular surgeon
|February 24, 2026
概括
补偿性透症在内镜胸腔交感切除术 (ETS) 后用于手掌透症发生早期,可能会自发改善. 有限的,单级的同情切除术,最好是R4,可以降低这种并发症的风险.
科学领域:
- 胸部外科手术 胸部外科手术
- 神经外科 神经外科
- 皮肤病学 皮肤病学
背景情况:
- 补偿性过是手掌过的内镜胸腔交切除术 (ETS) 的主要并发症.
- 补偿性超的时间过程和长期预测因素尚不清楚.
研究的目的:
- 调查ETS后补偿性过症的时间演变.
- 为了确定补偿性过症,复发和患者满意度的预测因子,在手掌过症的ETS之后.
主要方法:
- 这是一项多中心的回顾性研究,对226名接受双边剪贴式ETS的患者进行了多中心的回顾性研究.
- 患者按手术水平分层 (R3,R4,R2-R4,不对称).
- 补偿性过症的严重程度在6个月,12个月和长期随访 (平均98个月) 后被评估;用于分析的逻辑回归.
主要成果:
- 在84.5%的患者中实现了完全的手掌干燥.
- 补偿性过发生在48.7%,仅在手术后6个月内发生,其中28.2%显示自发回归.
- 多级R2-R4共感切除预测了更高的补偿性过风险 (OR=2.18);单级R4与较低的负担有关. 复发,而不是补偿性过,导致了不满.
结论:
- 补偿性过症在ETS后的早期出现,并且可以自发地部分消失.
- 多级交感切除术增加了补偿性过症的风险,但没有提高疗效;建议偏好有限的单级 (R4) 方法.
- 手术水平的选择,戒烟和患者咨询对于管理ETS后的结果至关重要.
相关概念视频
Endoscopic Studies II: Thoracocentesis
1.7K
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.7K
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K


